Louise Wang Zhiying Humphrey

Array ( [id] => 7011348 [patent_doc_number] => 20050065064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Identification of allosteric peptide agonists of CXCR4' [patent_app_type] => utility [patent_app_number] => 10/637911 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7347 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065064.pdf [firstpage_image] =>[orig_patent_app_number] => 10637911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7116716 [patent_doc_number] => 20050070017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications' [patent_app_type] => utility [patent_app_number] => 10/636730 [patent_app_country] => US [patent_app_date] => 2003-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 176 [patent_figures_cnt] => 176 [patent_no_of_words] => 40422 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10636730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977930 [patent_doc_number] => 20050287648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/523038 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 65405 [patent_no_of_claims] => 124 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287648.pdf [firstpage_image] =>[orig_patent_app_number] => 10523038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966416 [patent_doc_number] => 20050233313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Methods and reagents for identifying inhibitors of viral protease activity' [patent_app_type] => utility [patent_app_number] => 10/521381 [patent_app_country] => US [patent_app_date] => 2003-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18340 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20050233313.pdf [firstpage_image] =>[orig_patent_app_number] => 10521381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7060981 [patent_doc_number] => 20050003342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Viral marker' [patent_app_type] => utility [patent_app_number] => 10/626832 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14701 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003342.pdf [firstpage_image] =>[orig_patent_app_number] => 10626832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5793467 [patent_doc_number] => 20060014148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Igg fc/hiv-gp120/c3d fusion protien' [patent_app_type] => utility [patent_app_number] => 10/518523 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3267 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014148.pdf [firstpage_image] =>[orig_patent_app_number] => 10518523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291803 [patent_doc_number] => 20040110922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Chimeric proteins for prevention and treatment of hiv infection' [patent_app_type] => new [patent_app_number] => 10/466836 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12258 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110922.pdf [firstpage_image] =>[orig_patent_app_number] => 10466836 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473963 [patent_doc_number] => 20040097409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => new [patent_app_number] => 10/624947 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33113 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20040097409.pdf [firstpage_image] =>[orig_patent_app_number] => 10624947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122401 [patent_doc_number] => 20050014230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Preparation of fully human antibodies' [patent_app_type] => utility [patent_app_number] => 10/622003 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9714 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014230.pdf [firstpage_image] =>[orig_patent_app_number] => 10622003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7395194 [patent_doc_number] => 20040018177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Vacination method' [patent_app_type] => new [patent_app_number] => 10/345000 [patent_app_country] => US [patent_app_date] => 2003-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12231 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018177.pdf [firstpage_image] =>[orig_patent_app_number] => 10345000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369335 [patent_doc_number] => 20040092723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Compositions and methods for the intracellular delivery of antibodies' [patent_app_type] => new [patent_app_number] => 10/618179 [patent_app_country] => US [patent_app_date] => 2003-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5722 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092723.pdf [firstpage_image] =>[orig_patent_app_number] => 10618179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7347518 [patent_doc_number] => 20040248084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors' [patent_app_type] => new [patent_app_number] => 10/612603 [patent_app_country] => US [patent_app_date] => 2003-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28855 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248084.pdf [firstpage_image] =>[orig_patent_app_number] => 10612603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 484963 [patent_doc_number] => 07217506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-15 [patent_title] => 'Mutational profiles in HIV-1 protease correlated with phenotypic protease inhibitor resistance' [patent_app_type] => utility [patent_app_number] => 10/519035 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6636 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/217/07217506.pdf [firstpage_image] =>[orig_patent_app_number] => 10519035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7177687 [patent_doc_number] => 20050123899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Anti-hiv agent' [patent_app_type] => utility [patent_app_number] => 10/500774 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7528 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123899.pdf [firstpage_image] =>[orig_patent_app_number] => 10500774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 373221 [patent_doc_number] => 07473524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-06 [patent_title] => 'Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance' [patent_app_type] => utility [patent_app_number] => 10/518525 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5305 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/473/07473524.pdf [firstpage_image] =>[orig_patent_app_number] => 10518525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590895 [patent_doc_number] => 20060040347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Use of triplex structure DNA in transferring nucleotide sequences' [patent_app_type] => utility [patent_app_number] => 10/602663 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 13896 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040347.pdf [firstpage_image] =>[orig_patent_app_number] => 10602663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463836 [patent_doc_number] => 20040101534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Adjuvant-free peptide vaccine' [patent_app_type] => new [patent_app_number] => 10/603094 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9855 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101534.pdf [firstpage_image] =>[orig_patent_app_number] => 10603094 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5914084 [patent_doc_number] => 20060128941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Pokeweed antiviral protein polypeptides with antiviral activity' [patent_app_type] => utility [patent_app_number] => 10/518142 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18861 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20060128941.pdf [firstpage_image] =>[orig_patent_app_number] => 10518142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304012 [patent_doc_number] => 20040115621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Ancestral viruses and vaccines' [patent_app_type] => new [patent_app_number] => 10/441926 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25317 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115621.pdf [firstpage_image] =>[orig_patent_app_number] => 10441926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306912 [patent_doc_number] => 20040116684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Ancestral viruses and vaccines' [patent_app_type] => new [patent_app_number] => 10/441949 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29544 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116684.pdf [firstpage_image] =>[orig_patent_app_number] => 10441949 [rel_patent_id] =>[rel_patent_doc_number] =>)